ANTILYMPHOCYTIC SERUM IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

[1] CASPARY EA, 1965, ANN NY ACAD SCI, V122, P182

[2] FIELD EJ, 1969, LANCET, V1, P893

[3] STRESS EFFECT OF ANTILYMPHOCYTE SERUM [J]. BRITISH MEDICAL JOURNAL, 1969, 2 (5651) : 227 - &

[4] OCCURRENCE OF LIPEMIA IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J]. NEUROLOGY, 1957, 7 (03) : 175 - 188

[5] KONIGSMARK BW, 1963, J NEUROPATH EXP NEUR, V22, P643

[6] LEIBOWITZ S, 1968, LANCET, V1, P569

[7] LEIBOWITZ S, 1968, Clinical and Experimental Immunology, V3, P753

[8] PATERSON PHILIP Y., 1966, ADVANCE IMMUNOL, V5, P131, DOI 10.1016/S0065-2776(08)60273-4

[9] DIALYSABLE PEPTIDE AS CAUSATIVE FACTOR IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J]. NATURE, 1962, 196 (4858) : 1005 - &

[10] TURK JL, 1967, LANCET, V1, P249

[1] CASPARY EA, 1965, ANN NY ACAD SCI, V122, P182

[2] FIELD EJ, 1969, LANCET, V1, P893

[3] STRESS EFFECT OF ANTILYMPHOCYTE SERUM [J]. BRITISH MEDICAL JOURNAL, 1969, 2 (5651) : 227 - &

[4] OCCURRENCE OF LIPEMIA IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J]. NEUROLOGY, 1957, 7 (03) : 175 - 188

[5] KONIGSMARK BW, 1963, J NEUROPATH EXP NEUR, V22, P643

[6] LEIBOWITZ S, 1968, LANCET, V1, P569

[7] LEIBOWITZ S, 1968, Clinical and Experimental Immunology, V3, P753

[8] PATERSON PHILIP Y., 1966, ADVANCE IMMUNOL, V5, P131, DOI 10.1016/S0065-2776(08)60273-4

[9] DIALYSABLE PEPTIDE AS CAUSATIVE FACTOR IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J]. NATURE, 1962, 196 (4858) : 1005 - &

[10] TURK JL, 1967, LANCET, V1, P249